Switching between long-acting insulin products requires careful attention to insulin concentration, dosing, glucose monitoring, and medical supervision. Toujeo to Lantus conversion is particularly important because both products contain insulin glargine but have different concentrations. Toujeo is insulin glargine U-300, while Lantus is insulin glargine U-100.
Toujeo to Lantus Conversion Calculator
What Is Toujeo?
Toujeo is a long-acting insulin containing insulin glargine U-300, meaning it contains 300 units of insulin glargine per milliliter. It is designed for subcutaneous administration and provides basal insulin coverage.
The concentration is an important distinction when comparing Toujeo with Lantus. Although both contain insulin glargine, they are not interchangeable by simply assuming that the same number of units will always produce identical dosing requirements.
FDA information for Toujeo notes that patients controlled on Lantus may require a higher daily Toujeo dose to maintain the same level of glycemic control.
That difference is one reason conversion guidance is useful when a healthcare professional changes a patient from one product to another.
What Is Lantus?
Lantus is a long-acting insulin containing insulin glargine U-100, with a concentration of 100 units per milliliter. It is used as basal insulin therapy in appropriate patients with diabetes.
The FDA-approved Lantus prescribing information provides specific instructions for switching from several insulin therapies. For a patient changing from once-daily Toujeo to once-daily Lantus, the recommended initial Lantus dosage is 80% of the discontinued Toujeo dose.
The reduction is specifically intended to reduce the likelihood of hypoglycemia during the transition.
What Does the Toujeo to Lantus Conversion Calculator Do?
The calculator asks for two pieces of information:
- Current Toujeo dose in units/day
- Conversion method
The calculator then displays:
- Current Toujeo dose
- Conversion percentage
- Estimated initial Lantus dose
The primary conversion method in the tool is the FDA Lantus Label Method — 80%. A second 100% Unit-for-Unit Reference option is also included as a mathematical reference.
The 80% option corresponds to the FDA Lantus labeling for switching from once-daily Toujeo to once-daily Lantus.
The 100% option should not be interpreted as an individualized recommendation or as overriding the FDA-labeled 80% starting-dose guidance. It simply demonstrates what a mathematical unit-for-unit calculation would produce.
How to Use the Toujeo to Lantus Conversion Calculator
Using the calculator is straightforward.
Step 1: Enter the current Toujeo dose
Enter the current Toujeo dose in units per day.
For example, if the current dose is 40 units once daily, enter:
40
The calculator accepts decimal values as well, which can be useful for educational calculations involving non-whole-number doses.
Step 2: Select a conversion method
The calculator provides two choices:
- FDA Lantus Label Method — 80%
- Unit-for-Unit Reference — 100%
For an educational calculation reflecting the FDA Lantus prescribing information for a once-daily Toujeo-to-Lantus switch, select the 80% method.
Step 3: Select Calculate
Click Calculate to display the estimated result.
The calculator will show the original Toujeo dose, selected percentage, and resulting mathematical Lantus estimate.
Step 4: Review the result with your healthcare professional
The calculated number should not automatically become the dose you administer. Insulin changes can affect blood glucose levels and may require individualized adjustment and monitoring.
Toujeo to Lantus Conversion Formula
The basic calculation used by the calculator is:
Estimated Lantus Dose = Toujeo Dose × Conversion Percentage ÷ 100
For the FDA-label method:
Estimated Lantus Dose = Toujeo Dose × 0.80
For the 100% mathematical reference:
Estimated Lantus Dose = Toujeo Dose × 1.00
Example
If a person is currently taking 50 units/day of Toujeo and the 80% method is selected:
50 × 0.80 = 40 units/day
Therefore, the mathematical result displayed by the calculator would be:
40 units/day
This does not mean that 40 units/day is necessarily the correct dose for a particular person. The actual treatment plan should be determined by the prescribing clinician.
Toujeo to Lantus Conversion Table
The following table illustrates the mathematical result of applying the 80% conversion factor.
| Current Toujeo Dose | 80% Calculation | Mathematical Lantus Estimate |
|---|---|---|
| 10 units/day | 10 × 0.80 | 8 units/day |
| 20 units/day | 20 × 0.80 | 16 units/day |
| 30 units/day | 30 × 0.80 | 24 units/day |
| 40 units/day | 40 × 0.80 | 32 units/day |
| 50 units/day | 50 × 0.80 | 40 units/day |
| 60 units/day | 60 × 0.80 | 48 units/day |
| 70 units/day | 70 × 0.80 | 56 units/day |
| 80 units/day | 80 × 0.80 | 64 units/day |
| 90 units/day | 90 × 0.80 | 72 units/day |
| 100 units/day | 100 × 0.80 | 80 units/day |
These are mathematical examples based on the 80% calculation. They should not be interpreted as individualized prescriptions.
Understanding the 80% FDA Label Method
The most important feature of this calculator is the 80% conversion method.
The FDA Lantus prescribing information states that when switching from once-daily Toujeo U-300 to once-daily Lantus U-100, the recommended initial Lantus dosage is 80% of the Toujeo dosage being discontinued.
For example:
Toujeo = 60 units/day
Using the labeled conversion:
60 × 80% = 48 units/day
The calculator therefore displays 48 units/day as the estimated initial Lantus amount when the 80% method is selected.
The purpose of this calculation is not to establish a permanent dose. Rather, it reflects the labeled starting-dose conversion used when making this specific insulin transition.
Why Isn't the Conversion Simply Always 1:1?
Toujeo and Lantus both contain insulin glargine, but their concentrations differ.
- Toujeo: insulin glargine U-300
- Lantus: insulin glargine U-100
The concentration describes how many insulin units are contained in a given volume. The different formulations and pharmacologic characteristics mean that switching products requires consideration of the appropriate conversion guidance rather than assuming that the same dose will always be suitable.
FDA labeling for Toujeo also states that patients controlled on Lantus can be expected to require a higher daily Toujeo dose to maintain the same level of glycemic control.
Consequently, insulin glargine products should not be treated as though concentration differences are irrelevant.
Example 1: 30 Units of Toujeo
Suppose the current Toujeo dose is:
30 units/day
Using the 80% method:
30 × 0.80 = 24
The calculator would display:
Estimated initial Lantus dose: 24 units/day
Again, this is an educational calculation reflecting the labeled conversion method and should be reviewed with the prescribing healthcare professional before any insulin change.
Example 2: 45 Units of Toujeo
Suppose the current Toujeo dose is:
45 units/day
Calculation:
45 × 0.80 = 36
The mathematical result is:
36 units/day
This demonstrates that the calculator can also work with doses that are not multiples of 10.
Example 3: 72 Units of Toujeo
For a current dose of:
72 units/day
The 80% calculation is:
72 × 0.80 = 57.6
The calculator displays the numerical result using its formatting system.
Whether a particular dose should be rounded or adjusted for an actual injection is a clinical and device-specific decision. Users should not independently round an insulin dose simply because a calculator produces a decimal result.
80% Versus 100%: Understanding the Calculator Options
The calculator includes two calculation choices, but they have different purposes.
| Method | Calculation | Purpose |
|---|---|---|
| FDA Lantus Label Method | Toujeo × 0.80 | Reflects the Lantus labeling for switching from once-daily Toujeo |
| Unit-for-Unit Reference | Toujeo × 1.00 | Mathematical unit-for-unit comparison |
The 80% method is the clinically relevant labeled conversion for the specific once-daily Toujeo-to-Lantus switch described in the Lantus prescribing information.
The 100% method is included as a reference calculation. It should not be assumed to represent the correct starting dose for a patient.
Why Glucose Monitoring Matters During an Insulin Switch
Changing insulin products can affect blood glucose control. FDA labeling warns that changes in insulin regimen—including changes in insulin strength, manufacturer, type, injection site, or administration method—can affect glycemic control and may predispose a patient to hypoglycemia or hyperglycemia.
For this reason, glucose monitoring is particularly important when an insulin regimen changes.
A healthcare professional may consider factors such as:
- Current glucose patterns
- Fasting glucose
- Recent hypoglycemia
- Diabetes type
- Other diabetes medications
- Meal patterns
- Activity levels
- Kidney or liver considerations
- Previous insulin requirements
- Injection technique
- Individual response to the new insulin
The appropriate monitoring plan should come from the patient's healthcare team.
Important Safety Considerations
Insulin is a high-risk medication, and an incorrect dose can cause serious problems.
Hypoglycemia
Too much insulin relative to the body's needs can cause blood glucose to fall too low. Symptoms may include shakiness, sweating, hunger, dizziness, confusion, weakness, or changes in behavior. Severe hypoglycemia can become an emergency.
Hyperglycemia
Too little insulin can result in elevated blood glucose. Persistent or severe hyperglycemia can also require urgent medical attention, particularly when accompanied by symptoms such as vomiting, dehydration, difficulty breathing, or altered consciousness.
Never make an insulin conversion based solely on an online calculator
A calculator can perform arithmetic consistently, but it cannot evaluate a person's complete medical situation.
The FDA labeling specifically emphasizes careful management when changing insulin regimens because dosage changes can affect glucose control.
Toujeo and Lantus Are Different Concentrations
One of the most important concepts to understand is the difference between U-300 and U-100.
The "U" refers to insulin units, while the number indicates concentration.
| Product | Insulin | Concentration |
|---|---|---|
| Toujeo | Insulin glargine | U-300 |
| Lantus | Insulin glargine | U-100 |
This means the same volume does not contain the same number of insulin units.
The FDA Toujeo information also notes that the Toujeo pen's dose counter is designed specifically for Toujeo and that no conversion is required when using the Toujeo pen dose counter itself.
Who May Find This Calculator Useful?
The Toujeo to Lantus Conversion Calculator can be useful as an educational reference for:
- Patients researching insulin glargine products
- Caregivers learning about insulin conversion principles
- Healthcare students studying insulin dosing concepts
- Medical educators explaining U-300 versus U-100 insulin
- People preparing questions for their healthcare provider
- Anyone wanting to understand the arithmetic behind the labeled conversion
It should not replace professional prescribing, individualized treatment planning, or glucose monitoring.
What This Calculator Does Not Consider
A simple conversion calculator cannot account for every factor that may influence insulin therapy.
For example, it does not evaluate:
- A person's current blood glucose
- HbA1c
- History of hypoglycemia
- Diabetes type
- Body weight
- Kidney function
- Liver function
- Other insulin products
- Oral or injectable glucose-lowering medications
- Diet
- Exercise
- Illness
- Stress
- Pregnancy
- Injection technique
- Individual insulin sensitivity
Therefore, the output should be viewed strictly as a dose-conversion reference calculation.
Frequently Asked Questions
1. What is the Toujeo to Lantus conversion?
For a switch from once-daily Toujeo U-300 to once-daily Lantus U-100, the FDA Lantus prescribing information recommends an initial Lantus dose equal to 80% of the discontinued Toujeo dose.
2. What is the formula for converting Toujeo to Lantus?
The calculator uses:
Lantus dose = Toujeo dose × 0.80
when the FDA-label 80% method is selected.
3. Why does the calculator include a 100% option?
The 100% option provides a mathematical unit-for-unit reference. It does not replace the FDA-labeled 80% starting-dose recommendation for the specific once-daily Toujeo-to-Lantus switch.
4. If I take 40 units of Toujeo, what does the 80% calculation produce?
The mathematical calculation is:
40 × 0.80 = 32 units
So the calculator would display 32 units/day as the estimated initial Lantus dose under the 80% method.
5. Are Toujeo and Lantus the same insulin?
Both contain insulin glargine, but they have different concentrations. Toujeo is U-300, while Lantus is U-100. Their dosing and conversion instructions therefore should not automatically be assumed to be identical.
6. Can I switch from Toujeo to Lantus without talking to my doctor?
You should not independently change your insulin regimen. The appropriate dose and transition plan should be established by your healthcare professional, with appropriate glucose monitoring.
7. Does the calculator provide my personal insulin prescription?
No. It performs a mathematical conversion based on the dose and percentage entered. It cannot determine an individualized insulin prescription.
8. Why is the recommended Lantus starting dose 80% of Toujeo?
The Lantus prescribing information specifies 80% of the discontinued once-daily Toujeo dose as the recommended initial Lantus dose. The labeling states that the reduction lowers the likelihood of hypoglycemia.
9. Can I round the calculated Lantus dose?
Do not independently decide how to round an insulin dose. The appropriate dose and any rounding should be determined according to the prescribed insulin product, delivery device, and healthcare professional's instructions.
10. Does this calculator account for blood glucose levels?
No. The calculator only uses the Toujeo dose and selected conversion percentage. It does not analyze glucose readings, HbA1c, diet, exercise, other medicines, or medical history.
11. Is the 80% calculation appropriate for every insulin switch?
No. The 80% calculation described here specifically relates to switching from once-daily Toujeo to once-daily Lantus according to the Lantus labeling. Other insulin-to-insulin switches may have different recommendations.
12. Does Toujeo have a higher concentration than Lantus?
Yes. Toujeo is insulin glargine U-300, while Lantus is insulin glargine U-100. This concentration difference is an important consideration when changing products.
13. Why is glucose monitoring important after switching insulin?
Changing insulin regimens can affect glucose control and can increase the risk of either hypoglycemia or hyperglycemia. FDA labeling recommends careful management when changing insulin therapy.
14. Can this calculator be used for children?
The calculator does not determine whether a particular insulin conversion is appropriate for a child. Pediatric insulin therapy requires individualized medical management. Any pediatric insulin change should be discussed with the child's healthcare professional.
15. What should I do if my glucose changes significantly after switching insulin?
Contact your healthcare professional for guidance, particularly if glucose levels are repeatedly outside your target range or you experience symptoms of hypoglycemia or significant hyperglycemia. Severe symptoms or an emergency situation require prompt medical attention.
Final Thoughts
The Toujeo to Lantus Conversion Calculator is designed to make the arithmetic behind a specific insulin conversion easier to understand. For the labeled transition from once-daily Toujeo U-300 to once-daily Lantus U-100, the FDA prescribing information specifies an initial Lantus dose of 80% of the discontinued Toujeo dose.
The basic calculation is simple:
Toujeo dose × 0.80 = estimated initial Lantus dose
For example, 50 units/day of Toujeo produces a mathematical result of 40 units/day using the 80% method.
However, the calculation is only one part of an insulin transition. Individual factors, glucose patterns, other medications, diabetes type, and clinical circumstances can affect treatment decisions. Changes in insulin therapy should therefore be made with appropriate medical supervision and glucose monitoring.
Use this calculator as an educational and calculation reference, not as a substitute for individualized medical advice or a prescription.